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The function of the innate immune system is to provide a first-line of defense
against infectious organisms, via control of bacterial and viral growth using antigen
nonspecific means. These nonspecific immune effectors include macrophages and NK
cells, and certain cytokines elicited in response to "super antigens" on the infectious
agents. This innate system usually keeps most infectious agents from rapidly growing
while the adaptive immune system is generating a specific response complete with
immunologic memory. Compelling evidence suggests that space flight results in various
immunosuppressive effects, including reduced innate and adaptive immune responses.
We were particularly concerned with reduced NK activity at landing, and have asked
whether the microgravity component of space flight could be responsible for the
previously observed NK defect. We have conclusively demonstrated that simulated
microgravity as provided by the Synthecon bioreactors does not inhibit the NK function
nor the IL-2 activation of lymphokine-activated killing (LAK). Interleukin-2 is the key
cytokine responsible for activation of NK cells to express LAK, as well as to support
differentiation of lymphocytes during adaptive immune responses. Therefore, we have
disproved our original hypothesis based on poor NK in many of the astronauts upon
landing.
During the course of our studies, however, we have found that aspects of the IL-2
signaling and sequaelae which axe suboptimal or nonexistent, indicating that parts of the
immune response are not functioning in the manner considered normal, at least based on
those observed from flask cultures. The results we found include a lack of CD25 (IL-2Rcz
subchain) upregulation, which is needed for high affinity IL-2 signaling. The positive
control of lymphocytes cultured with 13_,-2 in flasks consistently upregulated IL-2Rot.
Further deficits include the lack of secondary cytokine induction in response to IL-2.
Secondary cytokines required for amplification of the innate immune response. We
tested for IL-113, TNFcx and IFN'f, and none were secreted after IL-2 stimulation in the
bioreactors, but all were secreted from the parallel flask cultures. These tests were
performed over various time points up to 8 days, and with several different donors.
Our future research is now directed to determine if mRNA for these cytokines and
the IL-2Rot is expressed, and if not would suggest a transcriptional block. We are also
testing the signal molecules themselves, and will look at the status of kinases believed to
functional in the early response of the IL-2 driven-pathway. It is difficult to know if the
bioreactor results actually represent real in vivo functioning, or whether the traditional
flask cultures are realistic.. To date we have accepted that the flask culture system for
lymphocytes represented the "normal', human immune status most accurately, but we are
questioning this.
There are no published articles as yet, although one manuscript is in preparation.
